Medicated liquid soap market seen reaching $2.73 billion by 2030

The Business Research Company says the medicated liquid soap market will grow from $1.59 billion in 2025 to $1.78 billion in 2026, with North America leading and Asia-Pacific set to grow fastest. The outlook is being driven by skin-health concerns, rising hygiene demand and wider use of specialized cleansing products.

Why it matters: - Medicated liquid soap is moving from a niche hygiene product to a broader skin-care and clinical-use category. - Growth in the market reflects rising demand for products that do more than cleanse, including antibacterial, antifungal and anti-inflammatory benefits. - The trend signals more spending on preventive skincare, prescription-grade hygiene products and sensitive-skin formulations.

What happened: - The Business Research Company released a report on the medicated liquid soap market on August 18, 2026. - The report estimates the market will rise from $1.59 billion in 2025 to $1.78 billion in 2026. - The report projects the market will reach $2.73 billion by 2030. - The forecast implies a 11.6% CAGR for 2025 to 2026 and an 11.4% CAGR through 2030.

The details: - Medicated liquid soap contains active pharmaceutical ingredients designed to treat or prevent specific skin conditions. - The products are used in clinical settings, dermatological care and daily personal hygiene routines. - The report cites growth drivers including higher rates of skin infections, more hygiene awareness, expanded infection control in healthcare settings and advances in dermatology treatments. - The forecast also points to rising demand for preventive skincare, greater use of prescription-grade hygiene products, growth in pharmaceutical e-commerce, stronger focus on sensitive-skin formulas and tighter regulatory scrutiny on topical products. - The report says the rising incidence of skin-related problems is a major driver, including acne, eczema, psoriasis, rashes and infections. - Environmental pollutants are weakening skin barriers and increasing irritation, which is lifting demand for medicated cleansing products. - Cancer Australia reported 18,257 new cases of skin melanoma in February 2025, representing 11% of all new cancer diagnoses, with 1,314 deaths in 2023. - The report says those figures underscore the pressure to manage skin health. - North America was the leading region in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market-hotspot infographics, and key technology and future-trend analysis. - The report includes a free sample and full report links: Download a free sample and View the full report.

Between the lines: - The market outlook suggests consumers and healthcare buyers are placing more value on products tied to prevention and treatment, not just basic cleansing. - North America’s lead suggests established demand, while Asia-Pacific’s faster growth points to expanding adoption across newer or larger consumer markets. - The report’s added dashboards and scoring tools indicate vendors and investors are looking for more granular market-selection data.

What's next: - The market is expected to keep expanding through 2030 as skin-health awareness, healthcare hygiene needs and specialty product demand remain strong. - Competition is likely to intensify around sensitive-skin formulations, e-commerce distribution and products positioned for therapeutic use. - The Business Research Company is directing readers to more information and its social channels for additional updates.